Corvus Pharmaceuticals, Inc. (CRVS) stock
Close on Nov 13, 2026Market cap $895.05MP/E –Yield –
Corvus Pharmaceuticals statistics
67 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 11, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 4.30
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 17.7%
- 10.8%
- Shares Change (QoQ)
- 0.24%
- 0.50%
- Float
- 58M
- 49M
- Shares Held by Insiders
- 30.5%
- 11.7%
- Shares Held by Institutions
- 84.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 18M
- –
- Short Interest Change
- -1.16%
- -0.80%
- Short % of Float
- 30.4%
- 9.01%
- Short % of Shares Outstanding
- 21.1%
- 6.30%
- Days to Cover
- 18.85
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $26.95
- –
- 52-Week Low
- $6.39
- –
- 20-Day Moving Average
- $10.44
- –
- 50-Day Moving Average
- $11.18
- –
- 200-Day Moving Average
- $13.99
- –
- Average True Range (14)
- $0.69
- –
- Price Change (1 Week)
- 0.95%
- -1.15%
- Price Change (1 Month)
- 8.02%
- -4.87%
- Price Change (3 Months)
- -28.6%
- -21.0%
- Price Change (6 Months)
- -13.6%
- -20.6%
- Price Change (YTD)
- 38.2%
- -23.6%
- Price Change (1 Year)
- 30.1%
- -22.4%
- Price Change (3 Years)
- 618.9%
- -29.5%
- Price Change (5 Years)
- 152.1%
- -77.9%
- Price Change (10 Years)
- -31.8%
- -65.4%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 997,048
- –
- Average Volume (90 Days)
- 994,629
- –
- Relative Volume
- 0.63
- 0.70
- Relative Strength Index (14)
- 49.3
- 43.4
- Volatility (1 Year)
- 179.0%
- 80.1%
- Beta (5 Years)
- 1.16
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -45.9%
- -49.9%
- Return on Assets (ROA)
- -42.3%
- -40.6%
- Return on Invested Capital (ROIC)
- -931.8%
- -32.9%
- Return on Capital Employed (ROCE)
- -32.5%
- -37.9%
Financial positionIndustry
- Current Ratio
- 13.38
- 3.30
- Quick Ratio
- 13.16
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$1.74M
- -$689.41K
- Employee Count
- 37
- 74
- WACC
- 10.9%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$61.41M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $202.90M
- $17.76M
- Net Cash Per Share
- $2.41
- $0.80
- Equity (Book Value)
- $208.32M
- $53.89M
- Book Value Per Share
- $2.48
- $1.50
- Tangible Book Value
- $208.32M
- $27.13M
- Working Capital
- $190.93M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$764.00K
- -$1.00M
- FCF Per Share
- -$0.57
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -7.19%
- -21.8%
- FCF Yield
- -5.36%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $0
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 31.64
- 0.23
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | CRVS | S&P 500 | Difference | CRVS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +13.1% | -3.0% | +16.1 pts | ||
| 3 months | -29.7% | -2.8% | −26.9 pts | ||
| Year to date | +38.2% | +11.5% | +26.7 pts | ||
| 1 year | +33.0% | +13.5% | +19.5 pts | ||
| 3 years | +700.0% | +77.7% | +622.3 pts | +100.0% | +21.1% |
| 5 years | +152.1% | +72.6% | +79.5 pts | +20.3% | +11.5% |
| 10 years | -33.3% | +308.2% | −341.5 pts | -4.0% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
18M CRVS shares were sold short on Oct 30, 2026, down 1.2% from the previous report, or 30.39% of the shares available to trade. At recent volumes it would take 18.9 days to buy them back. Over the last 20 sessions, 58.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 17,759,451 | -1.2% | 942,325 | 18.9 |
| Oct 15, 2026 | 17,967,756 | +1.0% | 1,203,205 | 14.9 |
| Sep 30, 2026 | 17,797,751 | +3.6% | 1,336,813 | 13.3 |
| Sep 15, 2026 | 17,180,341 | -9.7% | 946,307 | 18.2 |
| Aug 31, 2026 | 19,017,840 | -0.6% | 641,670 | 29.6 |
| Aug 14, 2026 | 19,127,098 | +4.5% | 849,105 | 22.5 |
| Jul 31, 2026 | 18,310,256 | +1.4% | 813,944 | 22.5 |
| Jul 15, 2026 | 18,061,919 | -4.0% | 1,434,623 | 12.6 |
| Jun 30, 2026 | 18,819,891 | +5.2% | 1,520,069 | 12.4 |
| Jun 15, 2026 | 17,882,834 | +3.2% | 1,244,138 | 14.4 |
| May 29, 2026 | 17,324,311 | -8.4% | 2,051,054 | 8.4 |
| May 15, 2026 | 18,910,283 | +2.9% | 1,579,015 | 12.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?